Skip to main content
Molecular Therapy. Methods & Clinical Development logoLink to Molecular Therapy. Methods & Clinical Development
. 2022 Jun 17;26:95. doi: 10.1016/j.omtm.2022.06.008

Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase

Rui Tao, Lin Xiao, Lifang Zhou, Zhaoyue Zheng, Jie Long, Lixing Zhou, Minghai Tang, Biao Dong ∗∗, Shaohua Yao
PMCID: PMC9218129  PMID: 35782593

Main Text

(Molecular Therapy: Methods & Clinical Development 19, 507–517; December 2020)

In the originally published version of this article, a statement of the co-first authorship was missed. The corrected statement of the co-first authorship now appears below.

Rui Tao1,3, Lin Xiao2,3, Lifang Zhou1, Zhaoyue Zheng2, Jie Long1, Lixing Zhou2, Minghai Tang1, Biao Dong2,∗, Shaohua Yao1,∗∗

1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China

2National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China

3These authors contributed equally

Correspondence: biaodong@scu.edu.cn

∗∗Correspondence: shaohuayao@scu.edu.cn

The authors regret this error.

Contributor Information

Biao Dong, Email: biaodong@scu.edu.cn.

Shaohua Yao, Email: shaohuayao@scu.edu.cn.


Articles from Molecular Therapy. Methods & Clinical Development are provided here courtesy of American Society of Gene & Cell Therapy

RESOURCES